# Primary cardiac lymphoma presenting as heart failure and atrioventricular block: case report

**Authors:** Jiyi Liu, Fengzhi Sun, Sixun Jia, Shulong Zhang, Yu Wang

PMC · DOI: 10.3389/fonc.2025.1635860 · Frontiers in Oncology · 2025-10-24

## TL;DR

A rare case of heart lymphoma causing heart failure and a severe heart rhythm issue was successfully treated with surgery, chemotherapy, and a pacemaker.

## Contribution

This case report highlights a successful treatment approach for primary cardiac lymphoma with heart failure and atrioventricular block.

## Key findings

- The patient achieved complete remission after surgical resection and fractionated R-CHOP chemotherapy.
- Physiological pacing improved outcomes in a patient with third-degree atrioventricular block due to PCL.
- No tumor recurrence was observed during the follow-up period.

## Abstract

Primary cardiac lymphoma (PCL) is an extremely rare and highly aggressive malignancy that typically presents with nonspecific cardiac symptoms. We report a case of primary cardiac diffuse large B-cell lymphoma (DLBCL) with initial manifestations of heart failure and third-degree atrioventricular block. The patient presented with progressive dyspnea, palpitations, and unintentional weight loss. Transthoracic echocardiography revealed a large right atrial mass. The patient first underwent surgical resection of the cardiac tumor, and pathological examination confirmed non-GCB subtype DLBCL. During fractionated R-CHOP chemotherapy, the patient experienced cardiac arrest, necessitating the urgent implantation of a temporary pacemaker. Subsequently, a permanent pacemaker was implanted using a physiological pacing strategy. After six cycles of chemotherapy and ongoing pacing support, the patient achieved complete remission, with no evidence of tumor recurrence during the follow-up period. This case suggests that for PCL patients presenting with heart failure and third-degree atrioventricular block, a combination of surgical resection, fractionated R-CHOP chemotherapy, and physiological pacing may contribute to a favorable outcome.

## Linked entities

- **Diseases:** Primary cardiac lymphoma (MONDO:0003917), heart failure (MONDO:0005252), atrioventricular block (MONDO:0000465), diffuse large B-cell lymphoma (MONDO:0018905)

## Full-text entities

- **Diseases:** dyspnea (MESH:D004417), palpitations (MESH:D006331), PCL (MESH:D008223), DLBCL (MESH:D016403), atrioventricular block (MESH:D054537), atrial mass (MESH:C536030), cardiac arrest (MESH:D006323), heart failure (MESH:D006333), malignancy (MESH:D009369), right (MESH:C535682), cardiac tumor (MESH:D006338), weight loss (MESH:D015431)
- **Chemicals:** R-CHOP (-)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12591941/full.md

## Figures

1 figure with captions in the complete paper: https://tomesphere.com/paper/PMC12591941/full.md

## References

26 references — full list in the complete paper: https://tomesphere.com/paper/PMC12591941/full.md

---
Source: https://tomesphere.com/paper/PMC12591941